Creon Minimicrospheres 35 2240 Unit (Protease CAPSULE (DELAYED RELEASE)) 2240 UNIT

CREON Minimicrospheres 35 2240 Unit is a delayed-release oral capsule containing protease enzymes. It is designed to aid digestion in individuals with exocrine pancreatic insufficiency, helping to break down proteins in the diet.

Strength

2240 UNIT

Manufacturer / TM Owner

BGP PHARMA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CREON Minimicrospheres 35 2240 Unit is used to support digestion in people who have difficulty producing enough digestive enzymes. This includes conditions like chronic pancreatitis or cystic fibrosis. The protease enzymes in this medication help the body break down proteins from food, facilitating nutrient absorption.

Side Effects

Common effects of CREON Minimicrospheres 35 2240 Unit may include improved digestion and reduced symptoms like bloating or discomfort after eating. Some users might experience mild gastrointestinal issues, such as nausea or diarrhea, as the body adjusts to the medication.

Precautions & Warnings

CREON Minimicrospheres 35 2240 Unit should be taken as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. The capsules should be swallowed whole and not crushed or chewed to ensure the delayed-release mechanism works effectively.

Avoid Interactions

CREON Minimicrospheres 35 2240 Unit may interact with certain medications, including antacids and other digestive enzymes. It is advisable to consult a healthcare provider before taking this medication with other drugs, especially if you are on a regular medication regimen.

Frequently Asked Questions

CREON Minimicrospheres 35 2240 Unit is used to aid digestion in individuals with exocrine pancreatic insufficiency, helping to break down proteins in the diet.

CREON Minimicrospheres 35 2240 Unit should be taken orally, with meals or snacks, and swallowed whole with plenty of water.

Common side effects may include mild gastrointestinal issues such as nausea, diarrhea, or bloating.

No, CREON Minimicrospheres 35 2240 Unit capsules should not be crushed or chewed. They should be swallowed whole to ensure the delayed-release mechanism works effectively.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.